MRI Interventions, Inc. Reports 79% Revenue Increase and Record Treatments in Second Quarter 2017
Aug 01, 2017 20:05 pm UTC| Business
IRVINE, Calif., Aug. 01, 2017 -- MRI Interventions, Inc. (OTCQB:MRIC) (the “Company”) today announced financial results for the second quarter ended June 30, 2017. 2017 Second Quarter and Recent Highlights Total...
Aug 01, 2017 20:05 pm UTC| Business
Commercial Financial Highlights Revenue of $35.6 million in second quarter 2017, an increase of 80 percent from second quarter 2016 2017 revenue guidance increased by $20 million, to $145-155 millionGAAP net income of...
TRACON to Report Second Quarter Company Highlights and Financial Results on August 8, 2017
Aug 01, 2017 20:05 pm UTC| Business
SAN DIEGO, Aug. 01, 2017 -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, wet age-related...
Varonis to Present at the Oppenheimer Technology, Internet & Communications Conference
Aug 01, 2017 20:05 pm UTC| Business
NEW YORK, Aug. 01, 2017 -- Varonis Systems, Inc. (NASDAQ:VRNS), a leading provider of software solutions that protect data from insider threats and cyberattacks, today announced its participation at the Oppenheimer 20th...
Aug 01, 2017 20:05 pm UTC| Business
MINNEAPOLIS, Aug. 01, 2017 -- SPS Commerce, Inc. (NASDAQ:SPSC), a leader in retail cloud services, today announced that management will present at the Oppenheimer 20th Annual Technology, Internet Communications...
Zafgen to Host Conference Call to Discuss Second Quarter 2017 Financial Results
Aug 01, 2017 20:05 pm UTC| Business
BOSTON, Aug. 01, 2017 -- Zafgen, Inc. (Nasdaq:ZFGN), a biopharmaceutical company dedicated to significantly improving the health and well-being of patients affected by metabolic diseases including type 2 diabetes and...
Prothena to Report Second Quarter 2017 Financial Results on August 8
Aug 01, 2017 20:05 pm UTC| Business
DUBLIN, Ireland, Aug. 01, 2017 -- Prothena Corporation plc (Nasdaq:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel protein immunotherapies, will...
Shiba Inu Whale Transactions Jump 115%, SHIB Price Nears Crucial $0.000016 Level